share_log

中国国际金融股份有限公司关于上海交易所《关于上海微创心脉医疗科技(集团)股份有限公司2023年年度报告的信息披露监管问询函》有关事项之核查意见

Verification opinion on relevant matters regarding the information disclosure and regulatory inquiry letter on the 2023 annual report of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. by China International Finance Co., Ltd. to Shanghai Stock Exchange.

Sensex a share ·  Jun 6
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more